Speaker: Dr. Kristjan Paulson, B.Sc, M.Sc, MD, FRCPC, Assistant Professor, Rady Faculty of Medicine, University of Manitoba. Chair, Leukemia Disease Site Group, CancerCare Manitoba, President, Cell Therapy Transplant Canada

At the end of this training, the participant will be able to:
1. Recognize the composition of the immune and blood system.
2. Explain what ALL is.
3. Identify the causes and risk factors in ALL
4. Recognize the signs and symptoms in ALL
5. Explain how ALL is diagnosed
6. Recognize the ALL subtypes
7. Describe the treatment plan and expected results of treatment in ALL
8. Compare the different possible treatments for ALL: Induction, consolidation, maintenance, drugs used, stem cell transplants, etc.
9. Explain the Minimal residual disease
10. Describe the implications in refractory or relapsed ALL
11. Recognize the importance of clinical trials in ALL
12. Explain treatment side effects and complications in ALL
13. Recognize the importance of care and management of side effects
14. Recognize the importance of vaccination and the impact of COVID-19 in ALL
15. The importance of ALL follow-up care plan
16. Explain the difference between long-term and late effects of treatments and name these effects in ALL
17. Recognize the importance of a healthy lifestyle in ALL
18. Discuss case studies